Physician profile
Michael K Obeng
NPI 1407811854
$497.09
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.41 · 2020: $14.66 · 2021: $272 · 2022: $57.35 · 2023: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $148.12 | 2021 | |
| Sientra, INC. | $138.11 | 2021-2022 | |
| Smith+Nephew, INC. | $101.95 | 2023 | Iodosorb Ointment 40g USA, Collagenase Santyl, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $46.84 | 2019-2022 | |
| Kls-Martin L.P. | $27.74 | 2023 | |
| Apollo Endosurgery US INC | $19.67 | 2022 | |
| Allergan, INC. | $14.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Obeng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.